National Health Executive News

The latest from National Health Executive

What is National Health Executive News?

Daily News from National Health Executive

And here’s today’s news from National Health Executive on Wednesday the 17th of July 2024.
England’s national guardian, Dr Jayne Chidgey-Clark, has said the “broken” NHS can be fixed if we begin listening to staff, after new analysis showed the declining perceptions of the freedom to speak up process. The National Guardian Office’s analysis shows that the number of people who feel secure raising concerns about unsafe clinical practice in the NHS has reached a five-year low.
Overall, around seven in 10 respondents to the NHS Staff Survey reported feeling safe to speak up about unsafe clinical practice, with approximately 11 in 20 believing their organisation would address such concerns. Slightly over three in five said they felt safe to speak up about anything, with half believing these concerns would be addressed.

NHS England and Prostate Cancer Research have joined forces to launch a new data platform that health leaders hope can transform patient care and save lives. NHSE has selected Prostate Progress as the first ‘driver project’ for its Data for Research and Development Programme, ultimately supporting innovative uses of health data.
Researchers hope to gain insights about prostate cancer patients by combining different sets of data to develop new treatments and tests improve diagnosis; monitor the safety of treatments; and plan new NHS services. The data includes patients who agree to participate in the initiative and the data they input themselves.

A new stroke treatment could be about to save the NHS millions of pounds, after final guidance was published by the National Institute for Health and Care Excellence.
Clinical evidence showed tenecteplase (ten-ect-e-plaze) was as effective as alteplase (alt-e-plaze), which NICE also recommends, in breaking up blood clots or preventing new blood clots from forming after an acute ischaemic (i-scheme-ic) stroke. Because tenecteplase costs less than alteplase, its use could potentially save the NHS millions.
And that’s the latest – Don’t forget to like and subscribe to make sure you receive every new bulletin & check out our website National Health Executive .com